GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » Pre-Tax Income

Changchun BCHT Biotechnology Co (SHSE:688276) Pre-Tax Income : ¥609 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Changchun BCHT Biotechnology Co's pretax income for the three months ended in Mar. 2024 was ¥64 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ¥609 Mil. Changchun BCHT Biotechnology Co's pretax margin was 23.73%.

During the past 7 years, Changchun BCHT Biotechnology Co's highest Pretax Margin was 33.76%. The lowest was 14.70%. And the median was 21.76%.


Changchun BCHT Biotechnology Co Pre-Tax Income Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changchun BCHT Biotechnology Co Pre-Tax Income Chart

Changchun BCHT Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial 263.84 486.65 261.57 197.69 563.76

Changchun BCHT Biotechnology Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.74 100.38 254.37 190.27 64.13

Competitive Comparison of Changchun BCHT Biotechnology Co's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Changchun BCHT Biotechnology Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changchun BCHT Biotechnology Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changchun BCHT Biotechnology Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Changchun BCHT Biotechnology Co's Pre-Tax Income falls into.



Changchun BCHT Biotechnology Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Changchun BCHT Biotechnology Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=633.267+0+-0.705+12.444+-81.251
=564

Changchun BCHT Biotechnology Co's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=59.155+0+-0.499+-1.869+7.345
=64

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥609 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changchun BCHT Biotechnology Co  (SHSE:688276) Pre-Tax Income Explanation

Changchun BCHT Biotechnology Co's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=64.132/270.288
=23.73%

During the past 7 years, Changchun BCHT Biotechnology Co's highest Pretax Margin was 33.76%. The lowest was 14.70%. And the median was 21.76%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changchun BCHT Biotechnology Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Changchun BCHT Biotechnology Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Changchun BCHT Biotechnology Co (SHSE:688276) Business Description

Traded in Other Exchanges
N/A
Address
No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012
Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.
Executives
Shi Nian Min Core technical personnel
Jiang Chun Lai Directors, senior managers, core technical personn
Zhu Chang Lin Core technical personnel
Wei Wei Senior management, core technical personnel
Yu Bing senior management
Liu Da Wei Senior management, core technical personnel
Meng Zhao Feng senior management
Zhang Zhe senior management
Kong Wei Directors, senior managers, core technical personn
Feng Da Qiang Supervisors

Changchun BCHT Biotechnology Co (SHSE:688276) Headlines

No Headlines